uBriGene uVivo™ LVV at CAR-TCR Summit 2026

uBriGene Biosciences is excited to participate in the 11th CAR-TCR Summit 2026, taking place September 16–17 in Boston, Massachusetts at The Westin Boston Seaport District. Visit uBriGene at Booth 20 to connect with our team and explore the latest advances in uVivo™ LVV Platform, our technology platform supporting the development of next-generation in vivo CAR-T therapies.

The CAR-TCR Summit is a flagship cell therapy forum bringing together leading KOLs, C-suite executives, senior industry leaders, and solution providers to advance CAR and TCR therapies from construct design and clinical development to manufacturing and commercialization. The event offers an opportunity to exchange industry-defining insights, explore emerging technologies, and build collaborations that can accelerate the delivery of life-saving therapies to patients.

This year, uBriGene will spotlight uVivo™ LVV Platform, designed to support targeted and efficient in vivo CAR-T development while addressing key challenges in lentiviral vector engineering, transduction efficiency, and scalable manufacturing.

Built on uBriGene’s lentiviral vector expertise, uVivo™ integrates innovative vector technologies, including detargeted Cocal-G lentiviral vectors, CD7-targeting technology, and advanced vector optimization, to support the development of next-generation in vivo CAR-T approaches.

🔬 Visit our poster presentation for a deeper look at the technology

Title: High-Yield In Vivo CAR-T Development Enabled by CD7 Nanobody and Detargeted Cocal-G Lentiviral Vectors

Poster Location: The Pavilion at The Westin Boston Seaport District | 425 Summer St, Boston, MA 02210, United States

Date & Time: Wednesday September 16, from 6:20 PM - 7:20 PM.

Connect With uBriGene in Boston

The future of cell therapy will require more than breakthrough biology, it will require innovative vector technologies, scalable manufacturing, and strong development partnerships

Whether you are advancing an in vivo CAR-T program, evaluating lentiviral vector technologies, or exploring a development and manufacturing partner for your cell and gene therapy pipeline, our team is ready to discuss how uBriGene can support your next step.

Visit Booth #20 during CAR-TCR Summit 2026 to discover uBriGene uVivo™ LVV Platform - An IND-Ready In Vivo CAR-T Technology, attend our poster presentation, or contact us to schedule a one-on-one meeting to discuss your project needs and partnership opportunities.